Skip to Content

What type of drug is Aliqopa?

Medically reviewed by Last updated on Sep 30, 2019.

Official Answer


Aliqopa (copanlisib) is a phosphatidylinositol-3-kinase (PI3K) inhibitor (kinase inhibitor).

It is indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least 2 prior treatments.

Follicular lymphoma is a slow-growing type of B-cell non-Hodgkin lymphoma, a cancer of the lymph system.

Aliqopa works by blocking several enzymes that promote cancer cell growth.

See also: medications for follicular lymphoma.

Related Medical Questions

Drug Information

Related Support Groups